Lv1
60 积分 2022-11-29 加入
Phenotypic POLE Variant Classification Identifies Patients Who May Have Favorable Prognosis and Benefit from Immunotherapy
4天前
已关闭
Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
6天前
已完结
Primary Resistance to Afatinib in a Patient with Lung Adenocarcinoma Harboring Uncommon EGFR Mutations: S768I and V769L
25天前
已完结
Lessons from Structural Biology for Understanding Drug Resistance in Gastrointestinal Stromal Tumors (GIST)
1个月前
已完结
Germline RAD51C mutations in ovarian cancer susceptibility
2个月前
已完结
Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma
2个月前
已完结
Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studies
2个月前
已完结
Identification of MET fusions in solid tumors: A multicenter, large scale study in China
2个月前
已完结
HER2-positive breast cancer
2个月前
已完结
Afatinib for the Treatment of NSCLC Harboring Uncommon EGFR Mutations: A Database of 693 Cases
3个月前
已完结
皖公网安备34019202002308
